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Introduction. We report a case of unilateral optic disc edema in a paediatric patient and discuss the concerns involved in diagnosis
and management of similar cases. Materials and Methods. Female aged 10 years was referred to our clinic due to progressive
visual loss of the LE over a few days. Her visual acuities (VA) were RE 10/10, LE 3/10, and she had a relative aﬀerent pupillary
defect and decreased colour vision in her LE and normal and painless eye movements. Fundoscopy showed a remarkably swollen
disc of the LE, and visual ﬁeld (VF) examination revealed enlargement of the blind spot and presence of horizontal inferior
papillomacular scotoma.Neurological examination,CT of brain and orbits and blood tests were normal.Visual evoked potentials
revealed an obstacle in the myelin substance before the optic chiasma of the LE. Results. The patient was treated with intravenous
methylprednoslone for 3 days and with oral methylprednizole for 15 days in progressively diminished daily doses. This led to
gradual improvement of VA, colour vision,and visual ﬁeld and resolution of optic disc oedema. Discussion.C o n c e r n st h a th a v et o
be taken into account regarding diagnosis and managementof similarcases are related to lumbar puncture indications, treatment
with corticosteroids, and appropriate followup.
1.Introduction
Optic neuritis in childhood is usually attributed to viral
causes (66%) and in most cases is bilateral, aﬀecting both
eyes simultaneously [1]. As for the therapeutic approach,
there are no clinical trials with corticosteroids in children.
In both unilateral and bilateral attacks with minor visual
loss, a periodical followup is recommended whereas in
unilateral and bilateral attacks with medium to severe visual
loss pharmaceutical therapy is advised with intravenous
methylprednisolone 15mg/kg/day for 3 days and periodical
followup. Per os therapy is not required. However, recent
studies compare methylprednisolone IV alone or followed
by oral corticosteroids, the second being more eﬀective in
preventing relapses [2].
Prognosis concerning vision is poor compared with
adults, although the risk of developing multiple sclerosis is
lower. Children with unilateral optic neuritis present better
vision prognosis (100% > 20/40) but develop multiple scle-
rosis (MS) more often compared to children with bilateral
optic neuritis (75%) [1]. However, other studies conclude
that bilateral and not unilateral optic neuritis in children
precedemore oftenMS [3]. PatientsdevelopingMS are older
attheonsetofopticneuritis(12yearsold)comparedtothose
who do not develop MS (9 years old) [1].
We present an interesting case of unilateral optic disc
edema in a paediatric patient and discuss the concerns
involved in diagnosis and management of similar cases.
2.Case Presentation
A 10-year-old female patient was referred to ourclinic dueto
progressive visual loss of the LE described as blurred vision2 Case Reports in Medicine
Figure 1: Fundus photography of the patient’s LE at the time of
admissionin which a remarkably swollen optic disc is illustrated.
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Figure 2: Normal visual ﬁeld examination in RE (a) Visual ﬁeld
examination with an enlargement of the blind spot and presence of
horizontalinferior papillomacular scotoma in LE (b).
Figure 3: Fundus photography of the patient’s LE ten days after
being released in which a remarkable improvement of the optic disc
edema is observed.
over 3 days without further symptoms. On examination, the
visualacuities(VA)were RE10/10,LE3/10;shehad arelative
aﬀerent pupillary defect and decreased colour vision in her
LE and normal and painless eye movements. Cycloplegic
examination revealed hypermetropia of +0.75sph in the
LE while fundoscopy showed remarkably swollen optic disc
(Figure 1). Her past medical history included periodical
bronchial asthmatic attacksand pneumonia a year ago, while
family history was clear.
Taking the diﬀerential diagnosis of optic disc edema
into consideration, further investigations were performed.
Visual ﬁeld examination revealed enlargement of the blind
spot and presence of horizontal inferior papillomacular
scotoma in the LE (Figure 2). Neurological examination was
thorough and unremarkable. Computed tomography (CT)
and magnetic resonance imaging (MRI) of brain and orbits
and all blood tests (full blood count, basic biochemical
analysis, CRP, blood coagulation examinations, FT3, FT4,
T S H ,A n t i - T P O ,A n t i - T G ,I g M ,I g E ,I g G ,I g A ,R F ,A N A ,
ANCA, and acL) were normal. The existence of adenovirus
and RSVantibodies wasattributedtocross-reaction ortothe
use of cortisone and thus was not evaluated. Finally, visual
evoked potentials of the occipital lobe revealed prolongation
oftheP100latenciesafterthestimulationoftheLE(172.8ms
inLEversus114.3msinRE,at17  ,and151.8msinLEversus
101.4msinRE,at70  )indicativeofanobstacleinthemyelin
s u b s t a n c eb e f o r et h eo p t i cc h i a s m a .
The patient was treated with intravenous methylpredni-
zolone 500mg daily for 3 days (Solumedrol 500mg, Pﬁzer)
and afterwards with oral methylprednizole (Medrol, Pﬁzer,
1mg/kgr body weight divided in 2 daily doses) for 15 days in
progressively diminished doses.
Five days after initiation of treatment (8 days after the
onset of symptoms) VA of the LE increased to 7/10, colour
vision and pupillary reﬂexes were recorded as normal, the
optic disc swelling improved, and the patient was released.
At the followup, ten days later VA of the LE was 10/10, there
was a remarkable improvement of the optic disc oedema
(Figure 3) and visual ﬁeld examination was normal. After 20
days the VA remained 10/10 and the optic disc was found
absolutely normal in fundoscopy.
Writteninformed consentwas obtainedfrom thepatient.Case Reports in Medicine 3
(−)( −)
Lumbar puncture
Intracranial hypertension
multiple sclerosis
CT/MRI orbits and brain (−)
Erythrocytes
sedimentation rate
Anterior ischemic optic
neuropathy
Posterior ischemic optic
neuropathy
Giant cell arteritis
Unilateral optic
disc edema
Primary tumors
Metastases
Thyroid ophthalmopathy
Demyelinating causes
Syphilis, toxoplasmosis,
lyme disease,
tuberculosis,
viral optic neuritis
Serological tests (IgG, IgM,
IgA, IgE, ANA, ANCA),
mantoux, chest radiogram
Painless progressive loss of vision
Ophthalmological examination/fundoscopy
Figure 4: Diﬀerential diagnosis of unilateral optic disc oedema and diagnostic approach.
3.Discussion
Diﬀerential diagnosis of optic disc oedema usually includes
intracranial tumours, benign intracranial hypertension, hy-
drocephalus and optic neuritis due to demyelinating, and
viral, infectious, and idiopathic causes. However, it can also
appear in ischemic optic neuropathy, neoplasmatic inﬁl-
tration, sarcoidosis, syphilis, and toxoplasmosis (Figure 4).
Furthermore, eye conditions such as uveitis, hypotonia, and
central retinal vein thrombosis or systemic diseases such as
malignant hypertension, severe anaemia, and hypoxaemia
can lead to disc oedema. Finally, compression due to Grave’s
disease, orbital lesions, and trauma can cause optic disc
oedema,aswellasthehereditaryLeberneuropathy[4].Many
of the situations included in the diﬀerential diagnosis are
extremely rare in children and seldom present by isolated
unilateral optic disc oedema.
There is still disagreement whether lumbar puncture
should be indicated in the diﬀerential diagnosis of unilateral
optic disc oedema in paediatric patients. In a study of 15
patients with unilateral optic disc oedema, 10 had idiopathic
intracranial hypertension. Neuroimaging did not reveal any
causes of the oedema, the other optic nerve was normal
and the visual disorders were similar to those with typical
bilateral oedema due to idiopathic intracranial hypertension
[5]. Although unilateral optic disc oedema due to idiopathic
intracranial hypertension among paediatric patients is a
rare condition, the use of lumbar puncture is not clearly
indicated. Nevertheless, despite being an interventional
diagnostic technique, lumbar puncture can be useful not
only to measure intracranial pressure, but also to analyse
cellularity, proteins, IgG production, and speciﬁc antibodies
including Aquaporin 4 Antibodies (AQP4-Ab), that may be
important in deﬁning followup and risks of evolution to
multiple sclerosis.
Similar scientiﬁc controversy exists regarding the cor-
ticosteroid treatment of paediatric patients with unilateral
optic disc oedema [6]. It is well known that longstanding
untreated disc oedema results in atrophy and permanent
vision impairment [4].Patientstreated withsteroidsonlyper
os show a higher relapse risk [7]. Although patients treated
with intravenous corticosteroids show an earlier improve-
ment, the long-term results (6 months-1year) are equal for
both groups. There is also a signiﬁcant relapse risk when
intravenous therapy is not followed by per os treatment.
In the 1980s, the optic neuritis treatment trial (ONTT)
was developed to evaluate corticosteroid treatment for optic
neuritis. This multicenter randomized clinical trial showed
that high-dose intravenous methylprednisolone followed by
oral prednisone accelerated visual recovery but did not
improve the 6-month or 1-year visual outcome compared
with placebo, whereas treatment with oral prednisone alone
did not improve the outcome and was associated with an
increased rate of recurrences of optic neuritis. Another
ﬁnding was that those who received intravenous corticos-
teroids followed by oral corticosteroids had a temporarily
reducedrisk ofdevelopmentofa seconddemyelinating event
consistent with MS [8]. On the other hand, considering
t h es i d ee ﬀects of steroids, it is diﬃcult to conclude in a
therapeuticprotocol. In any case, it is the clinical doctorwho
has to evaluate the quality of life, the potential dangers for
the patient, and the visual function and to take a decision
regarding treatment.
The followup of paediatric patients with unilateral
optic disc oedema should include examination of visual
acuity, colour vision, and pupillary reﬂexes. Also visual ﬁeld4 Case Reports in Medicine
examination, visual evoked potentials, and CT/MRI of brain
a n do r b i t ss h o u l db eu n d e r t a k e n .T h er i s ko fs u b s e q u e n t
MS development can now be reliably estimated and MRI is
established as the single most important predictor. However,
the Optic Neuritis Study Group found that still 25% of optic
neuritis with no lesions on brain MRI evolved to MS after
an initial episode; therefore a long followup by a paediatric
neurologist is strongly recommended [8–10].
Concerns that have to be taken into account regarding
diagnosis and treatment of similar cases are related to the
frequencyand type offollowup,since in themajority ofcases
theunderlyingcauseseemstobeaviral infectionandtherisk
of developing multiple sclerosis is rather low.
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